Screenin3D microfluidic technology is a game-changing approach for pre-clinical drug and therapy testing. At the Festival of Biologics in Basel, Dr Zagnoni presented a talk on our bespoke Onco-Chip^3D technology used for the screening of combination immunotherapies with CAR-Ts and their off-target cytotoxicity.

ScreenIn3D has been chosen to appear as an innovative company at SLAS2020 in San Diego.

Along with exhibiting, Michele Zagnoni will also be presenting our technology as part of the SLAS Ignite award. The SLAS Ignite Award recognizes the best start-up or emerging company exhibiting within Innovation AveNEW, a specially designated area within the exhibition.

Full details of the conference can be found on the SLAS website – https://www.slas2020.org/

You can also use the interactive floorplan to find where the ScreenIn3D booth will be located.

Interested in ELRIG’s latest free-to-attend networking event in association with Biocity, Scotland?

Hear speakers from industry & academia talk about recent developments in the design of biological 3D structures that enable cells to form or replicate tissues and create the possibilities of validating models of disease to support and drive translational research into Drug Discovery and Drug Development. (more…)

This year’s ‘Advances in Cell and Tissue Culture’ conference will take place over two days on Tuesday 4th and Wednesday 5th December 2018 in the Department of Chemical Engineering and Biotechnology at Cambridge University.

(more…)

Innovation AveNEW is a traditional highlight of the annual SLAS Conference and Exhibition. Through this program, SLAS provides start-up companies with tremendous exposure and prestige by granting complimentary exhibit space and in-kind support that enables the company’s participation at the SLAS Annual Conference & Exhibition.

(more…)